Last reviewed · How we verify

NCT06776536: DIE IO TRUS

Evaluation of Rectal Infiltration Depth and Length in Bowel Involvement of Deep Infiltrative Endometriosis (DIE) Using Intraoperative Transrectal Ultrasound (TRUS)

Recruiting now NA Last updated 15 January 2025
What this trial tests

NA trial testing Transrectal ultrasound of the bowel endometriosis during operation in Deep Infiltrating Endometriosis (DIE) in 15 participants. Currently enrolling.

Timeline
7 January 2025
Primary endpoint
7 April 2026
7 April 2026

Quick facts

Lead sponsorBaşakşehir Çam & Sakura City Hospital
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment15
Start date7 January 2025
Primary completion7 April 2026
Estimated completion7 April 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Başakşehir Çam & Sakura City Hospital

Who can join

Adults 18 to 55, female only, with Deep Infiltrating Endometriosis (DIE) or Transrectal Ultrasound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

we aim to evaluate the success of intraoperative transrectal ultrasound in measuring the depth and extent of bowel involvement in patients preoperatively diagnosed with intestinal endometriosis using transvaginal ultrasound and MRI, and who are planned for bowel resection

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Başakşehir Çam & Sakura City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06776536.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing